No Data
c.q. pharmaceutical holding (000950.SZ) distributed 0.3 yuan per 10 shares in the first three quarters. The record date for equity is November 15th.
c.q. pharmaceutical holding (000950.SZ) announced that the company will implement equity distribution in the first three quarters of 2024, with each 1...
Express News | C.Q. Pharmaceutical Holding and Novartis China embark on a strategic partnership in the field of radiopharmaceutical therapy.
Express News | C.Q. Pharmaceutical Holding: Securities Affairs Representative Cao Fang Resigns.
c.q. pharmaceutical holding (000950): Performance steadily recovering, accelerating industrial structure optimization.
Event: The company released the third quarter report for 2024. In the first three quarters of 2024, the company achieved revenues of 59.69 billion yuan (+2.2%); net income attributable to the mother is 0.29 billion yuan (-43.5%); non-net income attributable to the parent is 2.8 billion.
Heavy Pharmaceuticals Holdings: Report for the third quarter of 2024
c.q. pharmaceutical holding (000950.SZ): net income in the third quarter was 54.137 million yuan, a year-on-year increase of 1269.44%.
C.q. Pharmaceutical Holding (000950.SZ) announced its third-quarter report on October 24th. In the third quarter of 2024, the company achieved a revenue of 19.913 billion yuan, an increase of 12.70% year-on-year; the net income attributable to shareholders of the listed company was 54.137 million yuan, an increase of 1,269.44% year-on-year; the net income after deducting non-recurring gains and losses was 58.7922 million yuan, an increase of 1,342.83% year-on-year; and the basic earnings per share was 0.03 yuan/share.
No Data
No Data